Cargando…

Syndecan-1 (sCD138) levels in chronic lymphocytic leukemia: clinical and hematological correlations

BACKGROUND: Syndecan-1 (sCD138) has recently been suggested to predict the clinical course of early-stage chronic lymphocytic leukemia (CLL), but few studies have been reported. This study assessed the role of syndecan-1 in the prognosis of patients with CLL and its correlation with other prognostic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sharma, Monica, Tyagi, Seema, Tripathi, Preeti, Seth, Tulika
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6170314/ https://www.ncbi.nlm.nih.gov/pubmed/30310786 http://dx.doi.org/10.5045/br.2018.53.3.205

Ejemplares similares

Syndecan-1 (CD138), Carcinomas and EMT
por: Couchman, John R.
Publicado: (2021)

Circulating sCD138 and Some Angiogenesis-Involved Cytokines Help to Anticipate the Disease Progression of Early-Stage B-Cell Chronic Lymphocytic Leukemia
por: Wołowiec, Dariusz, et al.
Publicado: (2006)

The Intensity and Pattern of Syndecan-1 (CD138) Expression in Normal and Diseased Livers
por: Atique, Muhammad, et al.
Publicado: (2023)

Study on expression of plasma sCD138 in patients with hemorrhagic fever with renal syndrome
por: Li, Jing, et al.
Publicado: (2018)

Study of Bone Marrow Lymphocyte Subset in Acute Myeloid Leukemia
por: Dange, Prasad, et al.
Publicado: (2021)

Prevalence of Syndecan-1 (CD138) Expression in Different Kinds of Human Tumors and Normal Tissues
por: Kind, Simon, et al.
Publicado: (2019)

The Diagnostic Usefulness of Circulating Profile of Extracellular Matrix Components: Sulfated Glycosaminoglycans (sGAG), Hyaluronan (HA) and Extracellular Part of Syndecan-1 (sCD138) in Patients with Crohn’s Disease and Ulcerative Colitis
por: Derkacz, Alicja, et al.
Publicado: (2021)

Soluble syndecan-1 (CD138): is it useful as a prognostic factor in Korean patients with multiple myeloma?
por: Lee, Je-Jung
Publicado: (2010)

Disease Stage-Specific Pathogenicity of CD138 (Syndecan 1)-Expressing T Cells in Systemic Lupus Erythematosus
por: Liu, Lunhua, et al.
Publicado: (2020)

Utility of CD138/syndecan-1 immunohistochemistry for localization of plasmacytes is tissue-dependent in B6 mice
por: Meyerholz, David K., et al.
Publicado: (2022)

Relationship between circulating syndecan-1 levels (CD138s) and serum free light chains in monoclonal gammopathies
por: Cigliana, Giovanni, et al.
Publicado: (2015)

Hairy cell leukemia: A decade long experience of North Indian Hematology Center
por: Somasundaram, Venkatesan, et al.
Publicado: (2014)

Adult T-cell leukemia/lymphoma following elevation of serum levels of soluble cytokine receptors, sCD25 and sCD30
por: Takemoto, Shigeki, et al.
Publicado: (2014)

Syndecan-1 (CD138) deficiency increases Staphylococcus aureus infection but has no effect on pathology in a mouse model of peritoneal dialysis
por: Kowalewska, Paulina M., et al.
Publicado: (2016)

Risk of classical Kaposi sarcoma by plasma levels of Epstein-Barr virus antibodies, sCD26, sCD23 and sCD30
por: Pelser, Colleen, et al.
Publicado: (2010)

Preliminary Study of sCD14 and sCD163 as Predictors of Disease Severity and ICU Admission in COVID-19: Relation to Hematological Parameters, Blood Morphological Changes and Inflammatory Biomarkers
por: Attia, Hend, et al.
Publicado: (2023)

An expression signature of syndecan-1 (CD138), E-cadherin and c-met is associated with factors of angiogenesis and lymphangiogenesis in ductal breast carcinoma in situ
por: Götte, Martin, et al.
Publicado: (2007)

Heparanase-induced shedding of syndecan-1/CD138 in myeloma and endothelial cells activates VEGFR2 and an invasive phenotype: prevention by novel synstatins
por: Jung, O, et al.
Publicado: (2016)

Raised Serum Levels of Syndecan-1 (CD138), in a Case of Acute Idiopathic Systemic Capillary Leak Syndrome (SCLS) (Clarkson’s Disease)
por: Bøe, Ole Wilhelm, et al.
Publicado: (2018)

Genomic alterations in chronic lymphocytic leukemia and their correlation with clinico-hematological parameters and disease progression
por: Srinivasan, Vishrut K., et al.
Publicado: (2020)

The immunomodulatory role of tumor Syndecan-1 (CD138) on ex vivo tumor microenvironmental CD4(+) T cell polarization in inflammatory and non-inflammatory breast cancer patients
por: Saleh, Moshira Ezzat, et al.
Publicado: (2019)

A Comparison of Ki67, Syndecan-1 (CD138), and Molecular RANK, RANKL, and OPG Triad Expression in Odontogenic Keratocyts, Unicystic Ameloblastoma, and Dentigerous Cysts
por: Brito-Mendoza, Luisana, et al.
Publicado: (2018)

Persistent high plasma levels of sCD163 and sCD14 in adult patients with measles virus infection
por: Mascia, Claudia, et al.
Publicado: (2018)

Social and Financial Barriers to Optimum TKI Treatment in Patients with Chronic Myeloid Leukemia-A Knowledge-Attitudes-Practices Study from India
por: Gupta, Naveen, et al.
Publicado: (2021)

A Kinetic Study of CD83 Reveals an Upregulation and Higher Production of sCD83 in Lymphocytes from Pregnant Mice
por: Packhäuser, Katrin Regina Helene, et al.
Publicado: (2017)

Syndecan-1 (CD138) Modulates Triple-Negative Breast Cancer Stem Cell Properties via Regulation of LRP-6 and IL-6-Mediated STAT3 Signaling
por: Ibrahim, Sherif A., et al.
Publicado: (2013)

Increased Serum Levels of sCD14 and sCD163 Indicate a Preponderant Role for Monocytes in COVID-19 Immunopathology
por: Gómez-Rial, Jose, et al.
Publicado: (2020)

Elevated levels of sCD48 are inversely correlated with markers of disease activity in bullous pemphigoid
por: Treco, Emma, et al.
Publicado: (2022)

CD39 activity correlates with stage and inhibits platelet reactivity in chronic lymphocytic leukemia
por: Pulte, Dianne, et al.
Publicado: (2007)

Secondary Immunodeficiency in Hematological Malignancies: Focus on Multiple Myeloma and Chronic Lymphocytic Leukemia
por: Allegra, Alessandro, et al.
Publicado: (2021)

Molecular and clinical profiles of syndecan-1 in solid and hematological cancer for prognosis and precision medicine
por: Akl, Mohamed R., et al.
Publicado: (2015)

CD73 Promotes Chronic Lymphocytic Leukemia
por: Allard, David, et al.
Publicado: (2022)

Selective Cytotoxicity of Single and Dual Anti-CD19 and Anti-CD138 Chimeric Antigen Receptor-Natural Killer Cells against Hematologic Malignancies
por: Luanpitpong, Sudjit, et al.
Publicado: (2021)

Plasma CXCL10, sCD163 and sCD14 Levels Have Distinct Associations with Antiretroviral Treatment and Cardiovascular Disease Risk Factors
por: Castley, Alison, et al.
Publicado: (2016)

CD146/sCD146 in the Pathogenesis and Monitoring of Angiogenic and Inflammatory Diseases
por: Heim, Xavier, et al.
Publicado: (2020)

The Metal Coordination of sCD39 during ATP Hydrolysis
por: Chen, Wei, et al.
Publicado: (2001)

Phenotypic, Genomic and Functional Characterization Reveals No Differences between CD138(++) and CD138(low) Subpopulations in Multiple Myeloma Cell Lines
por: Paíno, Teresa, et al.
Publicado: (2014)

Value of CD16/CD66b/CD45 in comparison to CD55/CD59/CD45 in diagnosis of paroxysmal nocturnal haemoglobinuria: An Indian experience
por: Kotru, Mrinalini, et al.
Publicado: (2017)

Cytoplasmic azurophilic inclusion bodies in reactive plasmacytosis
por: Gupta, Aastha, et al.
Publicado: (2018)

Eosinophilic dermatosis of hematologic malignancy responding to dupilumab in a patient with chronic lymphocytic leukemia
por: Jin, Annie, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_o4p2jsig7fk3eo1aad01okls1c